Terms: = Sarcomas AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
143 results:
1. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
2. Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer.
Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
[TBL] [Abstract] [Full Text] [Related]
3. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract] [Full Text] [Related]
4. Sotorasib with panitumumab in chemotherapy-refractory KRAS
Kuboki Y; Fakih M; Strickler J; Yaeger R; Masuishi T; Kim EJ; Bestvina CM; Kopetz S; Falchook GS; Langer C; Krauss J; Puri S; Cardona P; Chan E; Varrieur T; Mukundan L; Anderson A; Tran Q; Hong DS
Nat Med; 2024 Jan; 30(1):265-270. PubMed ID: 38177853
[TBL] [Abstract] [Full Text] [Related]
5. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract] [Full Text] [Related]
6. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
7. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
8. Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study.
Wang J; Li M; Guo P; He D
J Orthop Surg Res; 2023 Jun; 18(1):465. PubMed ID: 37370182
[TBL] [Abstract] [Full Text] [Related]
9. Trends in the Incidence of Kaposi's Sarcoma and Non-Hodgkin Lymphoma in Northern Thailand during the Time Period of Universal Access to Antiretroviral treatment, 1998-2017.
Sripan P; Rerkasem A; Pongnikorn D; Chitapanarux I; Tangmunkongvorakul A; Ukranun W; Daoprasert K; Waisri N; Maneesai P; Srithanaviboonchai K; Aurpibul L
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1055-1061. PubMed ID: 36974561
[TBL] [Abstract] [Full Text] [Related]
10. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
[No Abstract] [Full Text] [Related]
11. MicroRNA-324-3p inhibits osteosarcoma progression by suppressing PGAM1-mediated aerobic glycolysis.
Weng Y; Duan W; Yu X; Wu F; Yang D; Jiang Y; Wu J; Wang M; Wang X; Shen Y; Zhang Y; Xu H
Cancer Sci; 2023 Jun; 114(6):2345-2359. PubMed ID: 36880587
[TBL] [Abstract] [Full Text] [Related]
12. Trends in incidence, survival and initial treatments of gynecological sarcoma: a retrospective analysis of the United States subpopulation.
He X; Dong Q; Weng C; Gu J; Yang Q; Yang G
BMC Womens Health; 2023 Jan; 23(1):10. PubMed ID: 36624439
[TBL] [Abstract] [Full Text] [Related]
13. Epidemiology and prediction model of patients with carcinosarcoma in the United States.
Chen M; He X; Yang Q; Zhang J; Peng J; Wang D; Tong K; Huang W
Front Public Health; 2022; 10():1038211. PubMed ID: 36518582
[TBL] [Abstract] [Full Text] [Related]
14. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study.
Kim SI; Kim JH; Lee C; Ha J; Jung KW; Lim MC
J Gynecol Oncol; 2023 Jan; 34(1):e9. PubMed ID: 36366811
[TBL] [Abstract] [Full Text] [Related]
15. The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors.
Douglass DP; Navid F; Weiss AR
Paediatr Drugs; 2022 Sep; 24(5):433-445. PubMed ID: 35902507
[TBL] [Abstract] [Full Text] [Related]
16. Desmoid tumors located in the abdomen or associated with adenomatous polyposis: French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).
Benech N; Bonvalot S; Dufresne A; Gangi A; Le Péchoux C; Lopez-Trabada-Ataz D; Meurgey A; Nicolas N; Orbach D; Penel N; Salas S; Saurin JC; Walter T; Lecomte T; Bouché O; ; ; ; ; ; ; ; ; ;
Dig Liver Dis; 2022 Jun; 54(6):737-746. PubMed ID: 35508462
[TBL] [Abstract] [Full Text] [Related]
17. The potential of PIK3CA, KRAS, BRAF, and apc hotspot mutations as a non-invasive detection method for colorectal cancer.
Alizadeh-Sedigh M; Mahmoodzadeh H; Fazeli MS; Haddadi-Aghdam M; Teimoori-Toolabi L
Mol Cell Probes; 2022 Jun; 63():101807. PubMed ID: 35296442
[TBL] [Abstract] [Full Text] [Related]
18. Bladder granulocytic sarcoma in a child: case report and literature review.
Tuna R; Karaman S; Oktar T; Anak S; Doğan Ö; Ünüvar A; Tuğcu D; Bayramoğlu Z; Kılıç SÇ; Çelik Aİ; Karakaş Z
Turk J Pediatr; 2022; 64(1):152-159. PubMed ID: 35286044
[TBL] [Abstract] [Full Text] [Related]
19. The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma.
Kang CW; Hannan KM; Blackburn AC; Loh AHP; Hong KC; Yuan GJ; Hein N; Drygin D; Hannan RD; Coupland LA
Invest New Drugs; 2022 Jun; 40(3):529-536. PubMed ID: 35201535
[TBL] [Abstract] [Full Text] [Related]
20. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or apc: A Multi-institutional Retrospective Study.
Nathenson MJ; Hu J; Ratan R; Somaiah N; Hsu R; DeMaria PJ; Catoe HW; Pang A; Subhawong TK; Amini B; Sweet K; Feister K; Malik K; Jagannathan J; Braschi-Amirfarzan M; Sheren J; Caldas Y; Moreno Tellez C; Rosenberg AE; Lazar AJ; Maki RG; Benedetto P; Cohen J; Trent JC; Ravi V; Patel S; Wilky BA
Clin Cancer Res; 2022 Sep; 28(18):4092-4104. PubMed ID: 35180772
[TBL] [Abstract] [Full Text] [Related]
[Next]
